Search

Chanh Duy Nguyen

Supervisory Patent Examiner (ID: 5233, Phone: (571)272-7772 , Office: P/2691 )

Most Active Art Unit
2609
Art Unit(s)
2623, 2775, 2609, 2691, 2629, 2787, 2774, 2675, 2618
Total Applications
776
Issued Applications
498
Pending Applications
50
Abandoned Applications
229

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6870614 [patent_doc_number] => 20030083304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment' [patent_app_type] => new [patent_app_number] => 10/251049 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11939 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083304.pdf [firstpage_image] =>[orig_patent_app_number] => 10251049 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/251049
CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment Sep 19, 2002 Abandoned
10/129381 Recombinant fusion molecules Sep 15, 2002 Abandoned
Array ( [id] => 499833 [patent_doc_number] => 07205142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/243243 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 11 [patent_no_of_words] => 11484 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205142.pdf [firstpage_image] =>[orig_patent_app_number] => 10243243 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/243243
Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof Sep 12, 2002 Issued
Array ( [id] => 6843061 [patent_doc_number] => 20030148408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => new [patent_app_number] => 10/241220 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 73296 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148408.pdf [firstpage_image] =>[orig_patent_app_number] => 10241220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/241220
Compositions and methods for the diagnosis and treatment of tumor Sep 10, 2002 Abandoned
Array ( [id] => 6739749 [patent_doc_number] => 20030157118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Tumour-specific animal proteins' [patent_app_type] => new [patent_app_number] => 10/226872 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26035 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157118.pdf [firstpage_image] =>[orig_patent_app_number] => 10226872 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/226872
Tumour-specific animal proteins Aug 22, 2002 Abandoned
Array ( [id] => 7467814 [patent_doc_number] => 20040053866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Tumor suppressor genes and their uses' [patent_app_type] => new [patent_app_number] => 10/226997 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13420 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053866.pdf [firstpage_image] =>[orig_patent_app_number] => 10226997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/226997
Tumor suppressor genes and their uses Aug 20, 2002 Abandoned
Array ( [id] => 6668779 [patent_doc_number] => 20030113762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Gleason grade 4/5 prostate cancer genes' [patent_app_type] => new [patent_app_number] => 10/222206 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11714 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113762.pdf [firstpage_image] =>[orig_patent_app_number] => 10222206 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/222206
Gleason grade 4/5 prostate cancer genes Aug 15, 2002 Abandoned
Array ( [id] => 376816 [patent_doc_number] => 07311914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'MAGE-A4 antigenic peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/218095 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20544 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/311/07311914.pdf [firstpage_image] =>[orig_patent_app_number] => 10218095 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/218095
MAGE-A4 antigenic peptides and uses thereof Aug 12, 2002 Issued
Array ( [id] => 6761209 [patent_doc_number] => 20030124571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Novel human septin and uses therefor' [patent_app_type] => new [patent_app_number] => 10/208304 [patent_app_country] => US [patent_app_date] => 2002-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22990 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124571.pdf [firstpage_image] =>[orig_patent_app_number] => 10208304 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/208304
Novel human septin and uses therefor Jul 28, 2002 Abandoned
Array ( [id] => 6696769 [patent_doc_number] => 20030108963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/205823 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42298 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108963.pdf [firstpage_image] =>[orig_patent_app_number] => 10205823 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/205823
Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer Jul 24, 2002 Abandoned
Array ( [id] => 6711005 [patent_doc_number] => 20030170754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Nuclear matrix proteins, polynucleotide sequences encoding them, and their uses' [patent_app_type] => new [patent_app_number] => 10/197857 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8655 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170754.pdf [firstpage_image] =>[orig_patent_app_number] => 10197857 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/197857
Nuclear matrix proteins, polynucleotide sequences encoding them, and their uses Jul 18, 2002 Abandoned
Array ( [id] => 6861071 [patent_doc_number] => 20030092079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions' [patent_app_type] => new [patent_app_number] => 10/193709 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21614 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092079.pdf [firstpage_image] =>[orig_patent_app_number] => 10193709 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/193709
Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions Jul 11, 2002 Abandoned
Array ( [id] => 6861075 [patent_doc_number] => 20030092083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Cage antigen' [patent_app_type] => new [patent_app_number] => 10/195117 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19186 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092083.pdf [firstpage_image] =>[orig_patent_app_number] => 10195117 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/195117
Cage antigen Jul 10, 2002 Abandoned
Array ( [id] => 906780 [patent_doc_number] => 07332287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Methods and compositions for diagnosing breast cancer' [patent_app_type] => utility [patent_app_number] => 10/192915 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 14127 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332287.pdf [firstpage_image] =>[orig_patent_app_number] => 10192915 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/192915
Methods and compositions for diagnosing breast cancer Jul 8, 2002 Issued
10/009861 Markers for prostate cancer Jul 2, 2002 Abandoned
Array ( [id] => 6813591 [patent_doc_number] => 20030073141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Monoclonal antibodies against a complex of human ACT and a serine protease' [patent_app_type] => new [patent_app_number] => 10/188607 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9103 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073141.pdf [firstpage_image] =>[orig_patent_app_number] => 10188607 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/188607
Monoclonal antibodies against a complex of human ACT and a serine protease Jul 1, 2002 Abandoned
Array ( [id] => 498547 [patent_doc_number] => 07204982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Compositions and methods for treatment and detection of multiple cancers' [patent_app_type] => utility [patent_app_number] => 10/188840 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 22934 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/204/07204982.pdf [firstpage_image] =>[orig_patent_app_number] => 10188840 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/188840
Compositions and methods for treatment and detection of multiple cancers Jul 1, 2002 Issued
Array ( [id] => 7166093 [patent_doc_number] => 20040076955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer' [patent_app_type] => new [patent_app_number] => 10/188832 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 176820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076955.pdf [firstpage_image] =>[orig_patent_app_number] => 10188832 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/188832
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer Jul 1, 2002 Abandoned
Array ( [id] => 6817678 [patent_doc_number] => 20030068636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer' [patent_app_type] => new [patent_app_number] => 10/176847 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38968 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068636.pdf [firstpage_image] =>[orig_patent_app_number] => 10176847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/176847
Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer Jun 20, 2002 Abandoned
Array ( [id] => 6861649 [patent_doc_number] => 20030092657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Modulation of PAX-2 for controlled apoptosis or survival of cells' [patent_app_type] => new [patent_app_number] => 10/175138 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8442 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092657.pdf [firstpage_image] =>[orig_patent_app_number] => 10175138 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/175138
Modulation of PAX-2 for controlled apoptosis or survival of cells Jun 18, 2002 Abandoned
Menu